Vanda shares underperformed the market so far this year, based on events of July 31, 2025.
3 reports, 1 independent
Updated Aug 7
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vanda shares underperformed the market so far this year, based on events of July 31, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vanda Pharmaceuticals (United States)
company in Washington D.C., United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksVanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of